Navigation Links
MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
Date:6/9/2008

by its forward-looking statements include, but are not limited to, Minrad International's limited operating history and business development associated with being a growth stage company; its dependence on key personnel; its need to attract and retain technical and managerial personnel; its ability to execute its business strategy; the intense competition it faces; its ability to protect its intellectual property and proprietary technologies; its exposure to product liability claims resulting from the use of its products; general economic and capital market conditions; financial conditions of its customers and their perception of its financial condition relative to that of its competitors; as well as those risks described under the heading "Risk Factors" of Minrad International's Form 10-KSB-A, filed with the Securities and Exchange Commission on April 21, 2008.. Although Minrad International, Inc. believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.

CONTACT:

Charles R. Trego, Jr.

Executive Vice President and CFO

E-mail: ctrego@minrad.com


'/>"/>
SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MINRAD International, Inc. Announces 2007 Financial Results
2. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
3. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
4. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
5. Jury Rules in Favor of Glycoproducts International, Inc.
6. Lockheed Martin Completes Acquisition of Eagle Group International, LLC
7. Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington
8. China Yingxia International, Inc. Reports First Quarter 2008 Results
9. Natural Alternatives International, Inc. Announces Third Quarter Results
10. China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
11. CalbaTech, Inc. Officially Changes Name to LifeStem International, Inc.; Lists New Symbol (LSTM) and Launches New Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Heska Corporation (Nasdaq: ... a leading provider of veterinary diagnostic and ... installation of the Company,s new DRI-CHEM® 7000 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, Customers receiving ... multi-patient clinical chemistry analyzer available to the ...
(Date:12/14/2009)... Enough To Wear Pink(TM) (TETWP), the grassroots cowboy ... anniversary at the signature Tough Enough To Wear ... (Wrangler NFR) in Las Vegas. While pink is ... support of the western industry and rodeo fans ... shirts, hats, bracelets and more. ,, Through ...
(Date:12/14/2009)... common CT procedures vary widely and are higher than generally thought, ... study led by University of California, San Francisco (UCSF) ... ... 14, 2009 -- Radiation doses from common CT procedures vary widely ... for cancer, according to a new study led by University of ...
(Date:12/14/2009)... The Hemophilia Federation of America (HFA) ... involving the Teamsters Local 929 and the American ... blood system depends on skilled workers to provide ... distilled into products such as clotting factor for ... ,, The Division of Blood Services at ...
(Date:12/14/2009)... small and shouldn,t worry most users, researcher says , , ... take antidepressants may have a small but statistically significant ... not on the medications, a new study finds. , ... stressed Dr. Jordan W. Smoller, an associate professor of ... a report in the Dec. 14 issue of ...
Breaking Medicine News(10 mins):Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:HFA Voices Blood Safety Concerns 2Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3
... women,s wombs over several assisted reproduction cycles that use ... cheaper than transferring two or more embryos at one ... series of patients who choose to have only one ... (eSET). , The authors of the Finnish study published ...
... Capture, Streamlines Health Records Documentation , ... ... Corporation , a leading developer of healthcare software solutions for ... national leader in enterprise content management and business process automation, ...
... Changes that Hold Health Care Providers Responsible when ... their products are implicated in harm to patients, ... wide contractual and legal protection that renders them ... University of Pennsylvania School of Medicine, ...
... Dealing with a difficult economy and a new ... the Managed Care Executive Group,s (MCEG) annual meeting held in ... Top Ten issues list the group produces each year. ... of strategic positives funded by the federal stimulus package that ...
... Most cervical cancers arose from strains covered by the shot, ... majority of invasive cervical cancers in New Mexico in the ... (HPV16) and HPV type 18 (HPV18), says a new study. ... HPV18-positive cancers were an average of five years younger than ...
... from human papilloma virus type 16 (HPV16) and HPV type ... cancers in New Mexico in the 1980s and 1990s, according ... issue of the Journal of the National Cancer Institute. ... HPV16- or HPV18-positive cancer was 5 years younger than that ...
Other Medicine News:Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 2Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 3Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 4Health News:iMedica and Imagetek Team up to Ease Transition to Paperless Medical Practice 2Health News:iMedica and Imagetek Team up to Ease Transition to Paperless Medical Practice 3Health News:iMedica and Imagetek Team up to Ease Transition to Paperless Medical Practice 4Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 2Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 3Health News:Economy and New President Shape This Year's Top Ten Issues Facing Managed Care Executives 2Health News:Economy and New President Shape This Year's Top Ten Issues Facing Managed Care Executives 3Health News:HPV Data May Aid Vaccine's Effectiveness 2Health News:Human papillomavirus genotype distribution in New Mexico cervical cancers 2
(Date:12/14/2009)... Seven leading cancer physicians ... Oncology Research participated in studies ... 2009 San Antonio Breast Cancer ... the Henry B. Gonzalez Convention ... . Fifteen others presented their ...
(Date:12/14/2009)... -- The board of directors of Eli Lilly and ... dividend for the first quarter of 2010 of $0.49 ... The dividend is payable March 10, 2010 to shareholders ... ,, February 12, 2010. ,, Lilly, a leading innovation-driven ... by applying the latest research from its own worldwide ...
(Date:12/14/2009)... 14 Corgenix Medical Corporation (OTC ... marketer of diagnostic test kits, and BG ... sciences company, announced today a supply agreement ... products in enzyme-linked immunosorbent assay (ELISA) microtiter ... is seeking regulatory clearance in the United ...
Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Recorders com Offers Free Dragon Medical 10 1 Upgrades 63138 1Recorders com Offers Free Dragon Medical 10 1 Upgrades 63138 2Happy Feet are Healthy Feet 3A Common Sense Tips on Taking Care of Your Feet to Survive the Holiday Season 63135 1Happy Feet are Healthy Feet 3A Common Sense Tips on Taking Care of Your Feet to Survive the Holiday Season 63135 2New discoveries could improve climate projections 11117 1New discoveries could improve climate projections 11117 2
... Conference Call Scheduled for 9:00 AM ET ... Dendreon Corporation (Nasdaq:,DNDN) announced today that it ... Phase 3, randomized, double-blind, placebo-controlled IMPACT,(IMmunotherapy for ... trial designed to assess the safety and ...
... Bioabsorbable Stent - Also,Slated for Presentation at Symposium, ... multiple clinical trials of,the world,s first pro-healing stent, ... week at the Transcatheter Cardiovascular,Therapeutics symposium, TCT 2008, ... Ph.D., of the Academic Medical Center in,Amsterdam will ...
Other Medicine Technology:Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3
... The Plan-Neofluar 63x/1.25 Oil Ph3 ... reflected-light reflection contrast. This method ... brightfield microscopy, such as cells ... a Petri dish. Moreover, this ...
... high-power, apochromatically corrected objectives ... the most exacting demands ... are suitable for visual ... 25 mm and feature ...
... redesigned by Nikon allowing the contrast direction ... the objective. That direction, once set, is ... 10x to 40x.,Apodized phase contrast objectives,Nikon's Apodized ... image by reducing internal reflections. The result ...
... Featuring an extra-high transmission rate, especially ... comparable to the CFI plan Achromat ... fluorescence observation and photomicrography. Because ... function as multipurpose objectives for brightfield, ...
Medicine Products: